Significance of phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysis.
Asma NaqiMohammad Ahmed KhanAbul Kalam NajmiPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
The addition of PI3K inhibitors decreased the risk of progression but increased the risk of toxicity.
Keyphrases